Immunomedics launches LeukoScan in Europe:
This article was originally published in Clinica
Executive Summary
Immunomedics has launched its LeukoScan radiolabelled monoclonal antibody in Germany, Austria, the UK and Ireland. The imaging agent is indicated for the detection of osteomyelitis involving long bones, particularly in diabetic patients with foot ulcers. Immunomedics, based in Morris Plains, New Jersey, expects to promote its imaging agent in other European countries within the next few months.